Living Cell Technologies appoints new US-based CEO [ + ]

Parties will combine to launch a new product but will remain separate entities [ + ]

Final quarter of FY08 down again, year the worst on record: PwC [ + ]

Special Phage Holdings wins NSW commercialisation award [ + ]

A Sydney company that has developed an innovative medical treatment for antibiotic resistant infections using bacteria-eating viruses has won the NSW government's 2008 BioFirstCommercialisation Award.

Arana Therapeutics adds new face to clinical research team [ + ]

IP Australia named as search and examination authority for US patent office [ + ]

Merck drug raltegravir shows good results as part of combination therapy [ + ]

The NHMRC has announced $29 million for medical research institute support services [ + ]

The biotechnology sector in Australia is fuming at the Federal Government, according to the editorial in the latest issue of ALS [ + ]

Australian researchers urge HIV-positive people on antiretrovirals to continue practising safe sex [ + ]

The twin laser technology, developed by physicists from ANU and Laboratoire Kastler Brossel in Paris in the laboratories of the Australian Research Council Centre of Excellence for Quantum-Atom Optics at ANU, may dramatically improve precision measurement ranging from atomic to outer-space applications.

Caution against targeting HMGB1 protein in inflammation drug development [ + ]

Rockeby receives $252,000 worth of orders for bird flu test [ + ]

Centre for bionics for NSW, international conference for Victoria [ + ]